ALPHA-2-DELTA LIGANDS TO TREAT OCD AND RELATED DISEASES

Details for Australian Patent Application No. 2003303037 (hide)

Owner WARNER-LAMBERT COMPANY LLC

Inventors BERTRAND, Claude, Philippe; CHOVET, Maria, Emilia, Pereira, Chicau; GEPPETTI, Pierangelo; TAYLOR, Jr., Charles, Price; THORPE, Andrew, John; WUSTROW, David, Juergen

Pub. Number AU-A-2003303037

PCT Number PCT/IB2003/0056

PCT Pub. Number WO2004/054577

Priority 60/433,491 13.12.02 US

Filing date 3 December 2003

Wipo publication date 9 July 2004

International Classifications

A61K 031/4245 - Oxadiazoles

A61P 011/00 Drugs for disorders of the respiratory system

A61P 011/14 Drugs for disorders of the respiratory system

A61K 031/195

A61K 031/197

A61K 031/401 - Proline

Event Publications

5 August 2004 Complete Application Filed

  Priority application(s): 60/433,491 13.12.02 US

19 August 2004 Application Open to Public Inspection

  Published as AU-A-2003303037

22 September 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003303038-Alpha2delta ligands for different pharmaceutical uses

2003303036-METHOD OF DECREASING HEPATIC GLUCOSE OUTPUT IN DIABETIC PATIENTS